Paper39201609
Disclosing the Novel Protective Mechanisms of Ocrelizumab in Multiple Sclerosis: The Role of PKC Beta and Its Down-Stream Targets.
Campagnoli LIM and 9 others. Int J Mol Sci, 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Disclosing the Novel Protective Mechanisms of Ocrelizumab in Multiple Sclerosis: The Role of PKC Beta and Its Down-Stream Targets. Papers, record 39201609. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201609
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Disclosing the Novel Protective Mechanisms of Ocrelizumab in Multiple Sclerosis: The Role of PKC Beta and Its Down-Stream Targets.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Protein Kinase C beta | Major topic |
| Multiple Sclerosis | Major topic |
| Antibodies, Monoclonal, Humanized | Major topic |
| Humans | |
| Female | |
| Male | |
| Adult | |
| Middle Aged | |
| Vascular Endothelial Growth Factor A | |
| Hypoxia-Inducible Factor 1, alpha Subunit | |
| Leukocytes, Mononuclear | |
| Superoxide Dismutase |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19900507 | Role of PKCbetaII and PKCdelta in blood-brain barrier permeability during aglycemic hypoxia. | Neurosci Lett | 2010 | https://conductscience.org/library/papers/19900507 | PubMed |
| 2 | 22300081 | Critical role of hypoxia sensor--HIF-1α in VEGF gene activation. Implications for angiogenesis and tissue injury healing. | Curr Med Chem | 2012 | https://conductscience.org/library/papers/22300081 | PubMed |
| 3 | 30813635 | Mechanisms of PKC-Mediated Enhancement of HIF-1α Activity and its Inhibition by Vitamin K2 in Hepatocellular Carcinoma Cells. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30813635 | PubMed |
| 4 | 29774057 | Ocrelizumab: a new milestone in multiple sclerosis therapy. | Ther Adv Neurol Disord | 2018 | https://conductscience.org/library/papers/29774057 | PubMed |
| 5 | 36046820 | Effect of troxerutin in counteracting hyperglycemia-induced VEGF upregulation in endothelial cells: a new option to target early stages of diabetic retinopathy? | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36046820 | PubMed |
| 6 | 20700133 | Protein kinase C activation modulates reversible increase in cortical blood-brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation. | J Cereb Blood Flow Metab | 2010 | https://conductscience.org/library/papers/20700133 | PubMed |
| 7 | 35981507 | Vascular Endothelial Growth Factor as a Predictive and Prognostic Biomarker for Multiple Sclerosis. | Neuroimmunomodulation | 2022 | https://conductscience.org/library/papers/35981507 | PubMed |
| 8 | 8756616 | Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. | Mol Cell Biol | 1996 | https://conductscience.org/library/papers/8756616 | PubMed |
| 9 | 20197783 | Activation of PKC isoform beta(I) at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain. | J Cereb Blood Flow Metab | 2010 | https://conductscience.org/library/papers/20197783 | PubMed |
| 10 | 30300457 | Multiple sclerosis - a review. | Eur J Neurol | 2019 | https://conductscience.org/library/papers/30300457 | PubMed |
| 11 | 32682869 | Treatment of Multiple Sclerosis: A Review. | Am J Med | 2020 | https://conductscience.org/library/papers/32682869 | PubMed |
| 12 | 25257521 | Farm animal serum proteomics and impact on human health. | Int J Mol Sci | 2014 | https://conductscience.org/library/papers/25257521 | PubMed |
| 13 | 17083617 | Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis. | Scand J Immunol | 2006 | https://conductscience.org/library/papers/17083617 | PubMed |
| 14 | 7897234 | Experimental autoimmune encephalomyelitis. Qualitative and semiquantitative differences in heat shock protein 60 expression in the central nervous system. | J Immunol | 1995 | https://conductscience.org/library/papers/7897234 | PubMed |
| 15 | 24328534 | Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients. | Autoimmunity | 2014 | https://conductscience.org/library/papers/24328534 | PubMed |
| 16 | 14664465 | Blood-brain barrier disruption in multiple sclerosis. | Mult Scler | 2003 | https://conductscience.org/library/papers/14664465 | PubMed |
| 17 | 38568026 | Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis. | Ann Neurol | 2024 | https://conductscience.org/library/papers/38568026 | PubMed |
| 18 | 29686116 | Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. | Neurology | 2018 | https://conductscience.org/library/papers/29686116 | PubMed |
| 19 | 38553104 | Relationship between inflammation and oxidative stress and its effect on multiple sclerosis. | Neurologia (Engl Ed) | 2024 | https://conductscience.org/library/papers/38553104 | PubMed |
| 20 | 32200342 | Unraveling a new player in multiple sclerosis pathogenesis: The RNA-binding protein HuR. | Mult Scler Relat Disord | 2020 | https://conductscience.org/library/papers/32200342 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42632066 | Sex- and age-specific associations of VEGFA polymorphisms with multiple sclerosis susceptibility. | Ann Med | 2026 | https://conductscience.org/library/papers/42632066 | PubMed |
| 40722952 | Manganese Superoxide Dismutase: Structure, Function, and Implications in Human Disease. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40722952 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ELAVL1 | 1994 | PubTator's text mining | https://conductscience.org/library/genes/1994 | NCBI Gene |
| HIF1A | 3091 | PubTator's text mining | https://conductscience.org/library/genes/3091 | NCBI Gene |
| HSPA4 | 3308 | PubTator's text mining | https://conductscience.org/library/genes/3308 | NCBI Gene |
| KRT20 | 54474 | PubTator's text mining | https://conductscience.org/library/genes/54474 | NCBI Gene |
| PRKCB | 5579 | PubTator's text mining | https://conductscience.org/library/genes/5579 | NCBI Gene |
| PRRT2 | 112476 | PubTator's text mining | https://conductscience.org/library/genes/112476 | NCBI Gene |
| SOD2 | 6648 | PubTator's text mining | https://conductscience.org/library/genes/6648 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39201609
GET https://conductscience.org/api/papers/v1/39201609/references?page=2